Know Cancer

forgot password

A Study of Survivorship Service Capacities Among Health Care Agencies in New York City

Not Enrolling
All Cancers

Thank you

Trial Information

A Study of Survivorship Service Capacities Among Health Care Agencies in New York City

To describe the range of services available to cancer survivors in the NYC area.

To determine organizations' need for assistance to enhance services for survivors.

Inclusion Criteria:

- To be eligible to participate in the study, an agency must:

1. Be a current provider of either:

- General health services (GHS), such as primary care, health education and
wellness, mental health services, home health care, palliative care, or
cancer screening and diagnosis;

- Cancer-specific medical treatments (CMT), such as cancer surgery,
radiation, chemotherapy, hormonal therapy; experimental therapies; cancer
pain and symptom management; rehabilitation services; post-treatment
monitoring and surveillance; or prophylactic treatments, such as
chemoprevention; or

- Any type of specialized 'post-cancer' or 'after-cancer' medical care or
support services (SMC) (i.e., psychotherapeutic, relationship and family,
psycho-educational,wellness and quality of life)

2. Be located within the five boroughs of New York City

3. Have been serving cancer patients for 12 months or longer, and

4. Be willing and able to identify an English-speaking representative, 21 years of
age or older as its designated key informant.

Exclusion Criteria:

- We will limit this study to provider agencies such as hospitals, diagnostic centers,
clinics, health and human service agencies, and grassroots community organizations
and public service settings that offer programs for cancer survivors. Independent
practitioners or private practice settings will not be surveyed. Our survey questions
are intended for major health services organizations and are not appropriate for
private practices settings.

We will use our screening questionnaire to determine where or not a given agency should be
included or excluded from the study AGENCY SCREENER.

Type of Study:


Study Design:

Time Perspective: Prospective

Outcome Measure:

To determine agencies' need for assistance to enhance services for survivors.

Outcome Time Frame:

2 years

Safety Issue:


Principal Investigator

David Loundsbury, PhD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center


United States: Institutional Review Board

Study ID:




Start Date:

April 2005

Completion Date:

April 2009

Related Keywords:

  • All Cancers
  • Cancer
  • Survivors



Memorial Sloan-Kettering Cancer CenterNew York, New York  10021